News Related to Central RVO

Related coverage linked through entity extraction aliases.

Zydus Lifesciences Launches India's First Indigenous Aflibercept Biosimilar ANYRA

Mar 13, 2026

Zydus Lifesciences launched ANYRA, India's first indigenously developed aflibercept biosimilar, on February 19, 2026, following an agreement with Regeneron Pharmaceuticals and Bayer for multiple ophthalmic indications.

Zydus Lifesciences Launches Semaglutide, Aflibercept Biosimilar; USFDA Clears Ahmedabad Plant

Feb 26, 2026

Zydus Lifesciences plans to launch Semaglutide injection in India after patent expiry and introduced ANYRA, India's first indigenous Aflibercept biosimilar. The USFDA cleared the company's Ahmedabad injectable facility with zero observations.